相关实验视频
Updated: Jul 19, 2025

08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.2K
细胞因子作为骨髓瘤患者的预后生物标志物:系统性审查和元分析
Gang Liu1, Ben Liu1, BinBin Liu1
1Fourth Department of Orthopedics, Cangzhou Central Hospital, Cangzhou, China.
概括
瘤中的巨细胞迁移抑制因子 (MIF) 和血清中的T细胞免疫球蛋白和粘素域-3 (Tim-3) 是 osteosarcoma 预后不佳的潜在生物标志物. 需要进一步的研究来确认它们的临床实用性.
科学领域:
- 在瘤学瘤学.
- 生物标志物 生物标志物
- 分子诊断学 分子诊断
背景情况:
- 骨髓瘤是儿童和青少年最常见的原发性骨癌.
- 细胞因子越来越多地被认为是它们在癌症预后中的作用.
- 确定可靠的生物标志物对于改善骨髓瘤患者的治疗结果至关重要.
结论:
- 瘤MIF和血清Tim-3显示出潜在的生物标志物,用于预测骨髓瘤的不良预后.
- 需要进行额外的大规模研究来验证这些发现的临床应用.
- 这些生物标志物可能会指导治疗策略并改善患者管理.
相关概念视频
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K

